A Comparison of Bleeding Events Among Patients on Apixaban, Rivaroxaban, and Warfarin for Atrial Fibrillation and/or Venous Thromboembolism

被引：1
|
作者：
Schaefer, Jordan K. [1 ]
Errickson, Josh [2 ,3 ]
Kong, Xiaowen [4 ]
Ali, Mona A. [5 ]
Chipalkatti, Naina [6 ]
Haymart, Brian [4 ]
Kaatz, Scott [7 ]
Krol, Gregory D. [8 ]
Sood, Suman L. [1 ]
Froehlich, James [4 ]
Barnes, Geoffrey D. [4 ]
机构：
[1] Univ Michigan, Div Hematol Oncol, Dept Internal Med, Ann Arbor, MI USA
[2] Univ Michigan, Consulting Stat Comp & Analyt Res, Ann Arbor, MI USA
[3] Univ Michigan, Ann Arbor, MI USA
[4] Univ Michigan, Div Cardiovasc Med, Dept Internal Med, Ann Arbor, MI USA
[5] Corewell Hlth William Beaumont Univ Hosp, Dept Heart & Vasc Serv, Royal Oak, MI USA
[6] Univ Michigan, Dept Internal Med, Ann Arbor, MI USA
[7] Henry Ford Hlth, Div Hosp Med, Detroit, MI USA
[8] Henry Ford Hlth, Dept Internal Med, Detroit, MI USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-184457
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Bleeding rates of Veterans taking apixaban or rivaroxaban for atrial fibrillation or venous thromboembolism
    Howe, Zachary
    Naville-Cook, Chad
    Cole, Derek
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2019, 47 (02) : 280 - 286
  • [2] Bleeding rates of Veterans taking apixaban or rivaroxaban for atrial fibrillation or venous thromboembolism
    Zachary Howe
    Chad Naville-Cook
    Derek Cole
    [J]. Journal of Thrombosis and Thrombolysis, 2019, 47 : 280 - 286
  • [3] APIXABAN AND RIVAROXABAN VERSUS WARFARIN FOR TREATMENT OF VENOUS THROMBOEMBOLISM IN OBESE PATIENTS
    Kafka, Wesley
    Cook, Stephen
    Ferris, Jessica
    Hill, Sharon
    [J]. CRITICAL CARE MEDICINE, 2020, 48
  • [4] Comparison of Adherence to Rivaroxaban Versus Apixaban Among Patients With Atrial Fibrillation
    McHorney, Colleen A.
    Peterson, Eric D.
    Laliberte, Francois
    Germain, Guillaume
    Nelson, Winnie W.
    Crivera, Concetta
    Schein, Jeffrey
    Lefebvre, Patrick
    [J]. CLINICAL THERAPEUTICS, 2016, 37 (11) : 2477 - 2488
  • [5] Clinical presentation and course of bleeding events in patients with venous thromboembolism, treated with apixaban or enoxaparin and warfarin
    Bleker, Suzanne M.
    Cohen, Alexander T.
    Buller, Harry R.
    Agnelli, Giancarlo
    Gallus, Alexander S.
    Raskob, Gary E.
    Weitz, Jeffrey I.
    Curto, Madelyn
    Sisson, Melanie
    Middeldorp, Saskia
    [J]. THROMBOSIS AND HAEMOSTASIS, 2016, 116 (06) : 1159 - 1164
  • [6] Comparative Effectiveness of Rivaroxaban, Apixaban, and Warfarin in Atrial Fibrillation Patients With Polypharmacy
    Mentias, Amgad
    Heller, Eric
    Vaughan Sarrazin, Mary
    [J]. STROKE, 2020, 51 (07) : 2076 - 2086
  • [7] Major Bleeding Risk During Anticoagulation with Warfarin, Dabigatran, Apixaban, or Rivaroxaban in Patients with Nonvalvular Atrial Fibrillation
    Adeboyeje, Gboyega
    Sylwestrzak, Gosia
    Barron, John J.
    White, Jeff
    Rosenberg, Alan
    Abarca, Jacob
    Crawford, Geoffrey
    Redberg, Rita
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2017, 23 (09): : 968 - 978
  • [8] Bleeding and Thromboembolic Events in Patients with Non-Valvular Atrial Fibrillation Treated with Apixaban or Rivaroxaban
    Abdullah, Ahmad Salihin
    Tan, Hwee Pheng
    Mohd Saffian, Shamin
    [J]. MALAYSIAN JOURNAL OF MEDICAL SCIENCES, 2022, 29 (02): : 164 - 172
  • [9] Major Bleeding in Patients With Atrial Fibrillation Receiving Apixaban or Warfarin
    Hylek, Elaine M.
    Held, Claes
    Alexander, John H.
    Lopes, Renato D.
    De Caterina, Raffaele
    Wojdyla, Daniel M.
    Huber, Kurt
    Jansky, Petr
    Steg, Philippe Gabriel
    Hanna, Michael
    Thomas, Laine
    Wallentin, Lars
    Granger, Christopher B.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (20) : 2141 - 2147
  • [10] Real world comparison of major bleeding risk among non-valvular atrial fibrillation patients newly initiated on apixaban, dabigatran, rivaroxaban or warfarin
    Lip, G. Y. H.
    Pan, X.
    Kamble, S.
    Kawabata, H.
    Mardekian, J.
    Masseria, C.
    Bruno, A.
    Phatak, H.
    [J]. EUROPEAN HEART JOURNAL, 2015, 36 : 1085 - 1085
12345